<DOC>
	<DOCNO>NCT02918864</DOCNO>
	<brief_summary>The purpose study evaluate feasibility , safety , preliminary efficacy integrate target dose intranasal oxytocin social cognitive skill group therapy school-aged child autism spectrum disorder ( ASD ) .</brief_summary>
	<brief_title>Oxytocin Social Cognitive Skills Groups</brief_title>
	<detailed_description>The study proof-of-concept , combination intervention design address individual treatment target presume influence social learn school-aged child autism spectrum disorder ( ASD ) . This proposal build upon prior research empirically support social cognitive skill train curriculum , NETT ( Nonverbal communication , Emotion recognition , Theory mind Training ) . NETT cognitive-behavioral intervention ( CBI ) nonverbal communication , emotion recognition , theory mind deficit youth ASD . In two-phase , 3 year , single-blind , contact control study , school-aged child ASD ( n=60 ) randomize 12-session , parallel group design Integrated Oxytocin NETT ( ION ) control social group condition ( facilitate play ) . The study aim evaluate safety , tolerability , efficacy integrate neuropeptide , oxytocin ( OT ) , social cognitive curriculum , well identify target change pre-treatment factor predictive response ION-ASD . Maintenance treatment effect also assess 1 month 3 month post-treatment .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Inclusion Criteria 1 . Male female outpatient , 811 year age inclusive 2 . Meet Diagnostic Statistical Manual Mental Disorders , 5th Edition Autism Spectrum Disorder . DSMV criterion establish clinician expertise individual ASD . Best estimate Diagnosis reach use DSMV criterion , Autism Diagnostic Observation Schedule ( ADOS2 ) Autism Diagnostic Interview ( ADIR ) , Autism Screening Interview . 3 . Mean score 7 less mentalizing item Strange Stories Test ( Highest possible score = 12 , item 2125 , 27 ) . 4 . Have Clinician 's Global ImpressionSeverity ( CGIS ) score ≥ 4 ( moderately ill ) Baseline . 5 . Verbal performance scale IQ ≥ 80 ( subtests WISCV ≥ 70 ) . 6 . If already receive stable concomitant medication , continuous participation precede 30 day prior Screening , electively initiate new modify ongoing medication duration study . For serotonergic agent , 6 month stable dose require . 7 . If already receive stable nonpharmacologic educational , behavioral , and/or dietary intervention , continuous participation precede 3 month prior Screening , electively initiate new modify ongoing intervention duration study . 8 . Have normal physical examination laboratory test result Screening . If abnormal , find ( ) must deem clinically significant Treating Clinician . 9 . Ability speak understand English sufficiently allow completion study assessment . 10 . Ability obtain write assent participant well write inform consent parent ( ) /legal guardian . Exclusion Criteria 1 . Patients born prior 35 week gestational age . 2 . Patients primary psychiatric diagnosis ASD . 3 . Patients medical history neurological disease , include , limited , epilepsy/seizure disorder ( except simple febrile seizure ) , movement disorder , tuberous sclerosis , fragile X , know genetic syndrome , know abnormal brain MRI/structural lesion . 4 . Pregnant female patient , sexually active female patient hormonal birth control sexually active female use least two type nonhormonal birth control . 5 . Patients evidence history malignancy significant hematological , endocrine , cardiovascular ( include rhythm disorder ) , respiratory , renal , hepatic , gastrointestinal disease . 6 . Patients one following : hemophilia ( bleed problem , recent nose brain injury ) , abnormal blood pressure ( hypotension hypertension ) , drug abuse , immunity disorder severe depression . 7 . Patients currently take OXT take INOXT past response . 8 . Patients Aberrant Behavior Checklist ( ABC ) Irritability subscale score &gt; 16 screen 9 . Patients sensitivity OXT component formulation . 10 . Patients unable tolerate venipuncture procedure blood sample . 11 . Patients foster care state define legal guardian . 12 . If arrhythmia present ECG , upon consultation cardiologist , deem clinically significant . 13 . Patients follow clinical lab result 1 . ALT/AST level ≥ 5 time upper limit normal , clinical jaundice occur 2 . Sodium level &gt; 152 mmol/L &lt; 128 mmol/L 3 . Potassium level &gt; 6 mmol/L nonhemolyzed sample 4 . Glucose level &gt; 11 mmol/L &lt; 2.8 mmol/L 5 . Hemoglobin level &lt; 100 g/L 6 . BUN level &gt; 100 mmol/L 7 . Creatinine level &gt; 100 µmol/L 8 . Osmolality level &gt; 330 mmol/kg</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Autism Spectrum Disorder</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Social Skills</keyword>
	<keyword>Social cognitive skill</keyword>
	<keyword>Cognitive Behavioral Intervention</keyword>
	<keyword>Combination treatment</keyword>
	<keyword>Syntocinon</keyword>
	<keyword>NETT ( Nonverbal communication , Emotion recognition , Theory mind Training )</keyword>
	<keyword>emotion recognition</keyword>
	<keyword>theory mind</keyword>
</DOC>